Highlights

[N2N] YoY TTM Result on 2012-09-30 [#3]


View:


Show?  YoY % Horiz. %

TTM Result
30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 CAGR
Revenue 37,459 34,429 30,239 24,954 19,143 13,292 14,956 16.53%
  YoY % 8.80% 13.86% 21.18% 30.36% 44.02% -11.13% -
  Horiz. % 250.46% 230.20% 202.19% 166.85% 128.00% 88.87% 100.00%
PBT 9,022 7,155 4,684 2,064 -1,573 -17,650 -15,397 -
  YoY % 26.09% 52.75% 126.94% 231.21% 91.09% -14.63% -
  Horiz. % -58.60% -46.47% -30.42% -13.41% 10.22% 114.63% 100.00%
Tax -13 -188 -220 -132 -209 -42 3 -
  YoY % 93.09% 14.55% -66.67% 36.84% -397.62% -1,500.00% -
  Horiz. % -433.33% -6,266.67% -7,333.33% -4,400.00% -6,966.67% -1,400.00% 100.00%
NP 9,009 6,967 4,464 1,932 -1,782 -17,692 -15,394 -
  YoY % 29.31% 56.07% 131.06% 208.42% 89.93% -14.93% -
  Horiz. % -58.52% -45.26% -29.00% -12.55% 11.58% 114.93% 100.00%
NP to SH 9,012 6,967 4,464 1,932 -1,782 -17,692 -15,394 -
  YoY % 29.35% 56.07% 131.06% 208.42% 89.93% -14.93% -
  Horiz. % -58.54% -45.26% -29.00% -12.55% 11.58% 114.93% 100.00%
Tax Rate 0.14 % 2.63 % 4.70 % 6.40 % - % - % - % -
  YoY % -94.68% -44.04% -26.56% 0.00% 0.00% 0.00% -
  Horiz. % 2.19% 41.09% 73.44% 100.00% - - -
Total Cost 28,450 27,462 25,775 23,022 20,925 30,984 30,350 -1.07%
  YoY % 3.60% 6.55% 11.96% 10.02% -32.47% 2.09% -
  Horiz. % 93.74% 90.48% 84.93% 75.86% 68.95% 102.09% 100.00%
Net Worth 163,293 157,790 46,807 40,598 37,548 40,265 57,802 18.89%
  YoY % 3.49% 237.10% 15.29% 8.12% -6.75% -30.34% -
  Horiz. % 282.50% 272.98% 80.98% 70.24% 64.96% 69.66% 100.00%
Dividend
30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 CAGR
Div 0 7,109 0 0 0 0 0 -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % 0.00% 100.00% - - - - -
Div Payout % - % 102.04 % - % - % - % - % - % -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % 0.00% 100.00% - - - - -
Equity
30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 CAGR
Net Worth 163,293 157,790 46,807 40,598 37,548 40,265 57,802 18.89%
  YoY % 3.49% 237.10% 15.29% 8.12% -6.75% -30.34% -
  Horiz. % 282.50% 272.98% 80.98% 70.24% 64.96% 69.66% 100.00%
NOSH 441,333 349,636 299,666 305,714 294,499 298,486 297,951 6.76%
  YoY % 26.23% 16.68% -1.98% 3.81% -1.34% 0.18% -
  Horiz. % 148.12% 117.35% 100.58% 102.61% 98.84% 100.18% 100.00%
Ratio Analysis
30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 CAGR
NP Margin 24.05 % 20.24 % 14.76 % 7.74 % -9.31 % -133.10 % -102.93 % -
  YoY % 18.82% 37.13% 90.70% 183.14% 93.01% -29.31% -
  Horiz. % -23.37% -19.66% -14.34% -7.52% 9.04% 129.31% 100.00%
ROE 5.52 % 4.42 % 9.54 % 4.76 % -4.75 % -43.94 % -26.63 % -
  YoY % 24.89% -53.67% 100.42% 200.21% 89.19% -65.00% -
  Horiz. % -20.73% -16.60% -35.82% -17.87% 17.84% 165.00% 100.00%
Per Share
30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 CAGR
RPS 8.49 9.85 10.09 8.16 6.50 4.45 5.02 9.15%
  YoY % -13.81% -2.38% 23.65% 25.54% 46.07% -11.35% -
  Horiz. % 169.12% 196.22% 201.00% 162.55% 129.48% 88.65% 100.00%
EPS 2.04 1.99 1.49 0.63 -0.61 -5.93 -5.17 -
  YoY % 2.51% 33.56% 136.51% 203.28% 89.71% -14.70% -
  Horiz. % -39.46% -38.49% -28.82% -12.19% 11.80% 114.70% 100.00%
DPS 0.00 2.03 0.00 0.00 0.00 0.00 0.00 -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % 0.00% 100.00% - - - - -
NAPS 0.3700 0.4513 0.1562 0.1328 0.1275 0.1349 0.1940 11.36%
  YoY % -18.01% 188.92% 17.62% 4.16% -5.49% -30.46% -
  Horiz. % 190.72% 232.63% 80.52% 68.45% 65.72% 69.54% 100.00%
Adjusted Per Share Value based on latest NOSH - 597,878
30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 CAGR
RPS 6.27 5.76 5.06 4.17 3.20 2.22 2.50 16.55%
  YoY % 8.85% 13.83% 21.34% 30.31% 44.14% -11.20% -
  Horiz. % 250.80% 230.40% 202.40% 166.80% 128.00% 88.80% 100.00%
EPS 1.51 1.17 0.75 0.32 -0.30 -2.96 -2.57 -
  YoY % 29.06% 56.00% 134.38% 206.67% 89.86% -15.18% -
  Horiz. % -58.75% -45.53% -29.18% -12.45% 11.67% 115.18% 100.00%
DPS 0.00 1.19 0.00 0.00 0.00 0.00 0.00 -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % 0.00% 100.00% - - - - -
NAPS 0.2731 0.2639 0.0783 0.0679 0.0628 0.0673 0.0967 18.88%
  YoY % 3.49% 237.04% 15.32% 8.12% -6.69% -30.40% -
  Horiz. % 282.42% 272.91% 80.97% 70.22% 64.94% 69.60% 100.00%
Price Multiplier on Financial Quarter End Date
30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 CAGR
Date 30/09/15 30/09/14 30/09/13 28/09/12 30/09/11 30/09/10 30/09/09 -
Price 0.6900 0.8800 0.4500 0.5000 0.2700 0.2900 0.2500 -
P/RPS 8.13 8.94 4.46 6.13 4.15 6.51 4.98 8.51%
  YoY % -9.06% 100.45% -27.24% 47.71% -36.25% 30.72% -
  Horiz. % 163.25% 179.52% 89.56% 123.09% 83.33% 130.72% 100.00%
P/EPS 33.79 44.16 30.21 79.12 -44.62 -4.89 -4.84 -
  YoY % -23.48% 46.18% -61.82% 277.32% -812.47% -1.03% -
  Horiz. % -698.14% -912.40% -624.17% -1,634.71% 921.90% 101.03% 100.00%
EY 2.96 2.26 3.31 1.26 -2.24 -20.44 -20.67 -
  YoY % 30.97% -31.72% 162.70% 156.25% 89.04% 1.11% -
  Horiz. % -14.32% -10.93% -16.01% -6.10% 10.84% 98.89% 100.00%
DY 0.00 2.31 0.00 0.00 0.00 0.00 0.00 -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % 0.00% 100.00% - - - - -
P/NAPS 1.86 1.95 2.88 3.77 2.12 2.15 1.29 6.29%
  YoY % -4.62% -32.29% -23.61% 77.83% -1.40% 66.67% -
  Horiz. % 144.19% 151.16% 223.26% 292.25% 164.34% 166.67% 100.00%
Price Multiplier on Announcement Date
30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 CAGR
Date 19/11/15 20/11/14 26/11/13 27/11/12 03/11/11 30/11/10 24/11/09 -
Price 0.9650 0.8500 0.4900 0.4900 0.2300 0.2800 0.3100 -
P/RPS 11.37 8.63 4.86 6.00 3.54 6.29 6.18 10.69%
  YoY % 31.75% 77.57% -19.00% 69.49% -43.72% 1.78% -
  Horiz. % 183.98% 139.64% 78.64% 97.09% 57.28% 101.78% 100.00%
P/EPS 47.26 42.66 32.89 77.54 -38.01 -4.72 -6.00 -
  YoY % 10.78% 29.71% -57.58% 304.00% -705.30% 21.33% -
  Horiz. % -787.67% -711.00% -548.17% -1,292.33% 633.50% 78.67% 100.00%
EY 2.12 2.34 3.04 1.29 -2.63 -21.17 -16.67 -
  YoY % -9.40% -23.03% 135.66% 149.05% 87.58% -26.99% -
  Horiz. % -12.72% -14.04% -18.24% -7.74% 15.78% 126.99% 100.00%
DY 0.00 2.39 0.00 0.00 0.00 0.00 0.00 -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % 0.00% 100.00% - - - - -
P/NAPS 2.61 1.88 3.14 3.69 1.80 2.08 1.60 8.49%
  YoY % 38.83% -40.13% -14.91% 105.00% -13.46% 30.00% -
  Horiz. % 163.12% 117.50% 196.25% 230.63% 112.50% 130.00% 100.00%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.


NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.



  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
MQ Trader
View candlestick stock charts with Technical indicators
MQ Affiliate
Be rewarded by being an MQ Affiliate
 
 

497  407  524  653 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 ASB 0.175+0.005 
 KANGER 0.22-0.015 
 MUIIND 0.115-0.005 
 MTOUCHE 0.06-0.005 
 PHB 0.03+0.005 
 SAPNRG 0.105-0.005 
 CAREPLS 3.18+0.03 
 HLT 1.66-0.01 
 PARLO 0.40-0.15 
 PASUKGB 0.0750.00 

FEATURED POSTS

1. The Equity Market Index Benchmark in Malaysia CMS
2. Trading Scenarios of Derivatives Bursa Derivatives Education Series
3. Derivatives 101 Bursa Derivatives Education Series
4. Why Trade FKLI? Bursa Derivatives Education Series
5. MQ Trader - Introduction to MQ Trader Affiliate Program MQ Trader Announcement!

TOP ARTICLES

1. TOPGLOV (7113) - Top Glove spent RM 354,738,027.11 in September for Share Buyback !!! Good or Bad? Bursa Malaysia Free Trading Education
2. Top Glove Investment: Is the EPF trading or investing?- A Misconception Van Gogh of Financial
3. 顶级手套业绩超越Maybank!股价却没反应,因为有一样东西悄悄地发生了变化!(Part 1/4) Valuation on Glove Sector - 陈剑 Good Articles to Share
4. Will Vaccine reduce glove usage? Koon Yew Yin Koon Yew Yin's Blog
5. LCTITAN - ALL-TIME HIGH SALES VOLUME AT ELEVATED ASPS, AND... Jom & Terry
6. (CHOIVO CAPITAL) LCTITAN (5284) Five Magic Words - Rising ASP’s, Falling Costs, Hurricane (or is it Butadiene?) Choivo Capital
7. [转贴] [Video:浅谈MY E.G.SERVICES BHD, MYEG, 0138] - James的股票投资James Share Investing James的股票投资James Share Investing
8. TOPGLOVE: Europe is facing a double-dip recession as coronavirus second wave arrives Van Gogh of Financial
PARTNERS & BROKERS